My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Quanterix Corporation

< Previous 1 2 3 Next >
Quanterix To Report Second Quarter 2024 Financial Results
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Releases Financial Results for the First Quarter of 2024
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix To Report First Quarter 2024 Financial Results
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Present at Cowen’s 44th Annual Health Care Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Releases Operating Results for Third Quarter 2023
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease Day
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
William P. Donnelly Appointed to Quanterix’s Board of Directors
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Appoints Vandana Sriram as Chief Financial Officer
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Releases Operating Results for Second Quarter 2023
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Tickers QTRX
Quanterix Releases Operating Results for First Quarter 2023
From Quanterix Corporation
Via Business Wire
Tickers QTRX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.